Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Giner

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working PartyJ P Sculier, M Paesmans, V Ninane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patientsJ Mallolas, J L Blanco, M Sarasa, et al.
Revista Clinica Espanola|November 22, 2024
Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?M Rubio-Rivas, J M Mora-Luján, A Montero Sáez, et al.
British Journal of Cancer|May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, J Lecomte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancerJ-P Sculier, J-J Lafitte, T Berghmans, et al.
The European Respiratory Journal|August 11, 2007
Chemotherapy improves low performance status lung cancer patientsJ P Sculier, J J Lafitte, M Paesmans, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working PartyJ P Sculier, M Paesmans, V Ninane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patientsJ Mallolas, J L Blanco, M Sarasa, et al.
Revista Clinica Espanola|November 22, 2024
Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?M Rubio-Rivas, J M Mora-Luján, A Montero Sáez, et al.
British Journal of Cancer|May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, J Lecomte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancerJ-P Sculier, J-J Lafitte, T Berghmans, et al.
The European Respiratory Journal|August 11, 2007
Chemotherapy improves low performance status lung cancer patientsJ P Sculier, J J Lafitte, M Paesmans, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
Pageof 8